GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Days Sales Outstanding

Core Laboratories (Core Laboratories) Days Sales Outstanding

: 77.35 (As of Mar. 2023)
View and export this data going back to 1995. Start your Free Trial

Core Laboratories's average Accounts Receivable for the three months ended in Mar. 2023 was $108.8 Mil. Core Laboratories's Revenue for the three months ended in Mar. 2023 was $128.4 Mil. Hence, Core Laboratories's Days Sales Outstanding for the three months ended in Mar. 2023 was 77.35.

The historical rank and industry rank for Core Laboratories's Days Sales Outstanding or its related term are showing as below:

CLB's Days Sales Outstanding is not ranked *
in the Oil & Gas industry.
Industry Median: 48.88
* Ranked among companies with meaningful Days Sales Outstanding only.

Core Laboratories's Days Sales Outstanding declined from Mar. 2022 (77.45) to Mar. 2023 (77.35).


Core Laboratories Days Sales Outstanding Historical Data

The historical data trend for Core Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.29 71.21 80.44 69.86 75.92

Core Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.45 74.75 72.21 74.07 77.35

Competitive Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories Days Sales Outstanding Distribution

For the Oil & Gas industry and Energy sector, Core Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Days Sales Outstanding falls into.



Core Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Core Laboratories's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (96.83 + 106.913) / 2 ) / 489.735*365
=101.8715 / 489.735*365
=75.92

Core Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

Days Sales Outstanding (Q: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (106.913 + 110.699) / 2 ) / 128.356*365 / 4
=108.806 / 128.356*365 / 4
=77.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core Laboratories  (NYSE:CLB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Core Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Laboratories (Core Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Executives
Katherine Murray director 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli officer: SVP, Gen Counsel & Secretary C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng director C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler officer: SVP C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith director P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique director P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland director DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno officer: President 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig officer: VP, Counsel & Secretary 6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett director 853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels officer: CAO & Treasurer 6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen director 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes director 6316 WINDFERN ROAD, HOUSTON TX 77040